Clusters in the EU-10 new member countries, an analysis.
Clusters in the EU-10 new member countries. Clusters as certified drivers of regional economic develpment.
Warsaw comes out as the leading biopharmaceutical cluster in EU 10.
The lack of regional specialisation might be an important factor explaining the European competitiveness gap with leading global peers. This is one of the main conclusions of the EU-10 cluster mapping report prepared by a team of academics lead by professor C. Ketels from the Stockholm School of Economics.
The report presents the first systematic mapping and analysis of regional clusters across the EU-10. It describes the differences in regional specialisation across 38 cluster categories, the changes that have occurred in cluster specialisation patterns in the last few years, and the nature of the leading locations across individual cluster categories. The cluster sector gained a total of 1 million jobs between 2000 and 2004, an increase of about 10%.
ScanBalt is mentioned in the Policy recommendations chapter: “ScanBalt, a network of regional clusters in biopharmaceuticals in the Baltic Sea Region,is an example of what might be useful.”
